STEPTRACKERIMMUNOLOGY + HEMATOLOGY | INNATE IMMUNITY | HIGH-YIELD REVIEW

Complement

A cascade of plasma proteins that opsonizes microbes, recruits inflammatory cells and punches holes in membranes — three ways in, one shared core at C3.

FOCUS ON
Activation: classical (IgM or IgG–antigen complexes bind C1q), lectin (mannose-binding lectin on microbial sugars), alternative (spontaneous C3 hydrolysis on microbial surfaces; factors B, D, properdin). All form a C3 convertase → C3a + C3b → C5 convertase → C5a + C5b → C5b–C9 MAC. Functions: C3b = opsonin (with IgG); C3a, C4a, C5a = anaphylatoxins (mast cell degranulation); C5a = neutrophil chemotaxis; MAC = lysis (key for Neisseria); C3b clears immune complexes. Regulators: C1 esterase inhibitor (deficiency → hereditary angioedema, ↑ bradykinin; ACE inhibitors worsen), DAF (CD55) and CD59 (deficient in PNH), factor H and I (aHUS, C3 glomerulopathy).
COMPONENT
ROLE
DEFICIENCY OR EXCESS
CLUE
C1q, C1r, C1s · C4 · C2
Classical pathway; C1q binds Fc of IgM (one) or IgG (two)
Early classical deficiency (C2 most common) → SLE-like disease, encapsulated infections
Poor immune-complex clearance
Mannose-binding lectin
Lectin pathway; cleaves C4 and C2 via MASPs
MBL deficiency → infections in infancy
Common, often mild
Factor B · factor D · properdin
Alternative pathway amplification loop on microbial surfaces
Properdin deficiency (X-linked) → Neisseria
—
C3
Central component; C3b opsonizes and forms convertases
C3 deficiency → severe recurrent pyogenic infections (encapsulated), immune-complex GN
Most severe single deficiency
C3a · C4a · C5a
Anaphylatoxins: mast cell histamine release, vasodilation
—
C5a is also the main chemoattractant
C5b–C9 (MAC)
Pore in membrane → lysis
Terminal deficiency → recurrent Neisseria (meningococcus, disseminated gonococcus)
Eculizumab (anti-C5) mimics it
C1 esterase inhibitor
Blocks C1r/C1s and kallikrein
Hereditary angioedema (AD): recurrent non-itchy swelling of face, airway, gut; ↓ C4
↑ bradykinin · no urticaria · ACE inhibitors contraindicated · C1-INH concentrate, icatibant, ecallantide
DAF (CD55) · CD59
GPI-anchored; disassemble convertase · block MAC on self cells
PNH (acquired PIGA mutation) → intravascular hemolysis, morning hemoglobinuria, thrombosis, pancytopenia
Flow cytometry · eculizumab, ravulizumab
Factor H · factor I · MCP (CD46)
Inactivate C3b on host surfaces
Atypical HUS (non-diarrheal), C3 glomerulopathy, macular degeneration (factor H variants)
Eculizumab for aHUS
CR1 (CD35) · CR2 (CD21) · CR3 (CD11b/CD18)
C3b on RBCs carries immune complexes to spleen · C3d boosts B cells · iC3b phagocytosis
CR3 is defective in LAD
EBV uses CR2
Complement consumption
Immune-complex disease uses up C3, C4
↓ C3 + ↓ C4: SLE, cryoglobulinemia, serum sickness · ↓ C3 only: PSGN, MPGN/C3G, aHUS
CH50 screens classical pathway

Picture it — the complement cascade

ClassicalC1q on IgM / IgGLectinMBL on mannoseAlternativeC3 + factors B, DC3 convertaseC1-INH ⊣factors H, I ⊣C3aanaphylatoxinC3bopsonin, clearsimmune complexesC5 convertaseC5aneutrophil chemotaxisC5bC5b–C9 MAClysis (Neisseria)CD59 ⊣DAF (CD55) ⊣convertasesred = regulators that protect host cells
Three entries, one coreClassical, lectin and alternative pathways each build a C3 convertase. C3b opsonizes and builds the C5 convertase; C3a and C5a recruit inflammation; C5b starts the membrane attack complex. Host cells are shielded by C1-INH, factors H and I, DAF and CD59.

Schematic diagrams, not to scale.

Mechanism — hereditary angioedema

↓ C1 esterase inhibitor
→
Unchecked kallikrein+ C1 activation (↓ C4)
→
↑ Bradykinin
→
Non-pitting, non-itchy swellingAirway, gut

ACE normally degrades bradykinin — ACE inhibitors cause the same angioedema and are forbidden in HAE.

Three pathways

PATHWAY
TRIGGER
FIRST PROTEINS
Classical
IgM/IgG bound to antigen
C1q, C1r, C1s → C4, C2
Lectin
Mannose on microbes
MBL + MASPs → C4, C2
Alternative
Microbial surface (no antibody)
C3(H₂O), factors B, D, properdin

How it's tested

COMMON CONFUSIONAllergic (histamine) angioedema itches and comes with hives and responds to antihistamines and epinephrine; HAE (bradykinin) has no hives and needs C1-INH or a bradykinin blocker.
THE TRAPLow C4 between attacks is the screening clue for hereditary angioedema — C3 stays normal.
YOUR APPROACHWhich pathway or regulator → what product is missing or excessive (opsonin, chemotaxin, MAC, bradykinin) → infection, autoimmunity or hemolysis pattern.

If you see… think…

Main opsonins → C3b and IgG
Neutrophil chemotaxis → C5a (also IL-8, LTB₄)
Recurrent meningococcal infection → C5–C9 deficiency
Lupus-like rash and nephritis in a child with low CH50 → C2 or C1q deficiency
Facial and laryngeal swelling without hives after a dental visit → hereditary angioedema
Angioedema after starting lisinopril → bradykinin accumulation
Dark morning urine, thrombosis, pancytopenia → PNH (CD55/CD59 loss)
Non-diarrheal HUS with low C3 → factor H or I defect
Low C3 with normal C4 after strep pharyngitis → post-streptococcal GN (alternative pathway)
Required vaccine before eculizumab → meningococcal